youtube.com/watch?v=Z526...

#Rachel’s #musicskt

This study from @fudan-university.bsky.social identifies oral Z526 as a promising anti-CAC agent that targets #NFκB signaling and #OxidativeStress, offering new hope for cancer-associated #Cachexia therapy. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

Oral compound #Z526 combats #cancerassociatedcachexia by inhibiting NF‑κB signaling and reducing #OxidativeStress, alleviating #MuscleAtrophy, improving strength and prolonging survival in #tumor‑bearing mice. @fudan-university.bsky.social

#OpenAccess: doi.org/10.1016/j.ge...

This new study systematically evaluates the anti-cancer-associated cachexia efficacy of the novel compound Z526 in multiple in vitro and in vivo models and explores its efficacy in modulating both NF-κB signaling and #OxidativeStress.

#OpenAccess:
www.sciencedirect.co...

This study by @fudan-university.bsky.social systematically evaluates the anti-cancer-associated cachexia efficacy of the novel compound (Z526) in multiple in vitro & in vivo models and explores its efficacy in modulating both NF-κB signaling & #OxidativeStress. #medsky

https://buff.ly/42wvIf5